Royalty Pharma

NASDAQ: RPRX · Real-Time Price · USD
36.34
-0.16 (-0.44%)
At close: Aug 15, 2025, 3:59 PM
36.08
-0.72%
After-hours: Aug 15, 2025, 07:21 PM EDT

Royalty Pharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
2.26B 2.35B 2.24B 2.29B
Cost of Revenue
n/a 560.66M 5.67M 23M
Gross Profit
2.26B 1.79B 2.23B 2.27B
Operating Income
1.29B 1.49B 977.5M 1.43B
Interest Income
47.34M 72.29M 78.33M 53.53M
Pretax Income
1.33B 1.7B 230.06M 1.24B
Net Income
859M 1.13B 42.83M 478.75M
Selling & General & Admin
237M 249.75M 227.3M 182.83M
Research & Development
2M 52M 177.11M 200.08M
Other Expenses
732M n/a 909.91M 475.84M
Operating Expenses
971M 862.4M 1.31B 858.75M
Interest Expense
225.51M 187.19M 187.96M 166.14M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
972M 862.4M 1.31B 858.75M
Income Tax Expense
472M n/a 187.23M 762.45M
Shares Outstanding (Basic)
447.63M 447.6M 437.96M 414.79M
Shares Outstanding (Diluted)
592.73M 602.9M 437.97M 607.17M
EPS (Basic)
1.92 3.41 0.10 1.15
EPS (Diluted)
1.45 2.53 0.10 1.15
EBITDA
1.29B 1.89B 928.56M 1.45B
EBIT
1.56B 1.89B 418.02M 1.43B
Depreciation & Amortization
n/a 395.13M 5.67M 23M